# Nanda Co., Ltd. – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/nanda-co-ltd/fa4fa83e-6b47-47f2-85b9-d80698f21c8b
Source feed: FDA_Inspections

> FDA inspection 1009120 of Nanda Co., Ltd., March 31, 2017. Classification: Voluntary Action Indicated (VAI). 11 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009120
- Company Name: Nanda Co., Ltd.
- Inspection Date: 2017-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)

Company: https://www.keypedia.com/companies/nanda-co-ltd/8f85a03c-34c8-400e-8da5-9c061eba76a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c